The perceived threatof medical malpracticeclaims makes a biggerimpression on radiologiststhan is warrantedby the actual risk of litigation.
The perceived threat of medical malpractice claims makes a bigger impression on radiologists than is warranted by the actual risk of litigation.
Dr. John F. Dick III and colleagues at Dartmouth mailed surveys in 2006 to 118 radiologists who participated in any of three registries associated with the Breast Cancer Surveillance Consortium in Colorado, New Hampshire, and western Washington. They compared findings with those of a similar survey performed in 2002. Researchers found that the perceived risk of being sued is four times higher than the reported rate of malpractice claims.
In 2006, radiologists estimated that they had a 35% chance of facing a mammography- related malpractice suit in the next five years. In 2002, they rated the likelihood at 41%, but actual claim reports reached 8% in 2002 and 10% in 2006 (AJR 2009;192:327-333).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.